High-throughput matrix screening identifies synergistic and antagonistic antimalarial drug combinations

[1]  C. Bogdan,et al.  Host-Parasite Interactions , 2016 .

[2]  Carol A. Mulrooney,et al.  Diversity-Oriented Synthesis Probe Targets Plasmodium falciparum Cytochrome b Ubiquinone Reduction Site and Synergizes With Oxidation Site Inhibitors , 2014, The Journal of infectious diseases.

[3]  K. Kirk,et al.  Diverse mutational pathways converge on saturable chloroquine transport via the malaria parasite’s chloroquine resistance transporter , 2014, Proceedings of the National Academy of Sciences.

[4]  Sam Michael,et al.  High-throughput combinatorial screening identifies drugs that cooperate with ibrutinib to kill activated B-cell–like diffuse large B-cell lymphoma cells , 2014, Proceedings of the National Academy of Sciences.

[5]  Ruili Huang,et al.  Chemical signatures and new drug targets for gametocytocidal drug development , 2014, Scientific Reports.

[6]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[7]  P. Roepe,et al.  A Process Similar to Autophagy Is Associated with Cytocidal Chloroquine Resistance in Plasmodium falciparum , 2013, PloS one.

[8]  P. Roepe,et al.  Anti-Plasmodial Polyvalent Interactions in Artemisia annua L. Aqueous Extract – Possible Synergistic and Resistance Mechanisms , 2013, PloS one.

[9]  M. Nandave,et al.  Targeting heat shock protein 90 for malaria. , 2013, Mini reviews in medicinal chemistry.

[10]  P. Roepe,et al.  Cytostatic versus cytocidal profiling of quinoline drug combinations via modified fixed-ratio isobologram analysis , 2013, Malaria Journal.

[11]  I. Coppens,et al.  Plasmodium falciparum ATG8 implicated in both autophagy and apicoplast formation , 2013, Autophagy.

[12]  A. Hain,et al.  Autophagy in Plasmodium, a multifunctional pathway? , 2013, Computational and structural biotechnology journal.

[13]  M. Mota,et al.  Torins are potent antimalarials that block replenishment of Plasmodium liver stage parasitophorous vacuole membrane proteins , 2013, Proceedings of the National Academy of Sciences.

[14]  P. Roepe,et al.  Function of resistance conferring Plasmodium falciparum chloroquine resistance transporter isoforms. , 2013, Biochemistry.

[15]  Gilean McVean,et al.  Multiple populations of artemisinin-resistant Plasmodium falciparum in Cambodia , 2013, Nature Genetics.

[16]  D. Sullivan,et al.  Synthesis and antimalarial efficacy of two-carbon-linked, artemisinin-derived trioxane dimers in combination with known antimalarial drugs. , 2013, Journal of medicinal chemistry.

[17]  L. Tilley,et al.  Altered temporal response of malaria parasites determines differential sensitivity to artemisinin , 2013, Proceedings of the National Academy of Sciences.

[18]  C. Wongsrichanalai.  Artemisinin resistance or artemisinin-based combination therapy resistance? , 2013, The Lancet. Infectious diseases.

[19]  M. H. Ensom,et al.  Pharmacokinetic Profile of Artemisinin Derivatives and Companion Drugs Used in Artemisinin-Based Combination Therapies for the Treatment of Plasmodium falciparum Malaria in Children , 2013, Clinical Pharmacokinetics.

[20]  S. Demo,et al.  Validation of the proteasome as a therapeutic target in Plasmodium using an epoxyketone inhibitor with parasite-specific toxicity. , 2012, Chemistry & biology.

[21]  L. C. Chen,et al.  Phase I safety, pharmacokinetic, and pharmacodynamic study of the oral phosphatidylinositol-3-kinase and mTOR inhibitor BGT226 in patients with advanced solid tumors. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[22]  T. Tsuboi,et al.  Autophagy-Related Atg8 Localizes to the Apicoplast of the Human Malaria Parasite Plasmodium falciparum , 2012, PloS one.

[23]  A. Cavanaugh,et al.  Behind the curtain: cellular mechanisms for allosteric modulation of calcium‐sensing receptors , 2012, British journal of pharmacology.

[24]  D. Schmatz,et al.  MK-4815, a Potential New Oral Agent for Treatment of Malaria , 2012, Antimicrobial Agents and Chemotherapy.

[25]  A. Holder,et al.  Extracellular ATP triggers proteolysis and cytosolic Ca2+ rise in Plasmodium berghei and Plasmodium yoelii malaria parasites , 2012, Malaria Journal.

[26]  Michael Costanzo,et al.  Systematic exploration of synergistic drug pairs , 2011, Molecular systems biology.

[27]  Renuka Kunte,et al.  WHO Guidelines for the treatment of malaria , 2011 .

[28]  X. Su,et al.  Chemical Genomic Profiling for Antimalarial Therapies, Response Signatures, and Molecular Targets , 2011, Science.

[29]  P. Roepe,et al.  Plasmodium falciparum resistance to cytocidal versus cytostatic effects of chloroquine. , 2011, Molecular and biochemical parasitology.

[30]  Leann Tilley,et al.  Artemisinin activity against Plasmodium falciparum requires hemoglobin uptake and digestion , 2011, Proceedings of the National Academy of Sciences.

[31]  J. Tarning,et al.  Pharmacokinetics of artemether and dihydroartemisinin in healthy Pakistani male volunteers treated with artemether-lumefantrine , 2010, Malaria Journal.

[32]  Bruce Russell,et al.  Spiroindolones, a Potent Compound Class for the Treatment of Malaria , 2010, Science.

[33]  Anang A. Shelat,et al.  Chemical genetics of Plasmodium falciparum , 2010, Nature.

[34]  Ravikant Ranjan,et al.  PfPI3K, a phosphatidylinositol-3 kinase from Plasmodium falciparum, is exported to the host erythrocyte and is involved in hemoglobin trafficking. , 2010, Blood.

[35]  T. Chou.  Drug combination studies and their synergy quantification using the Chou-Talalay method. , 2010, Cancer research.

[36]  R. Fisher.  On the Interpretation of χ2 from Contingency Tables, and the Calculation of P , 2010 .

[37]  Organización Mundial de la Salud.  Guidelines for the treatment of malaria , 2010 .

[38]  K. Kirk,et al.  Chloroquine Transport via the Malaria Parasite’s Chloroquine Resistance Transporter , 2009, Science.

[39]  K. Silamut,et al.  Artemisinin resistance in Plasmodium falciparum malaria. , 2009, The New England journal of medicine.

[40]  A. Janowsky,et al.  Discovery of dual function acridones as a new antimalarial chemotype , 2009, Nature.

[41]  S. Sheu,et al.  Crosstalk signaling between mitochondrial Ca2+ and ROS. , 2009, Frontiers in bioscience.

[42]  Rajarshi Guha,et al.  Utilizing high throughput screening data for predictive toxicology models: protocols and application to MLSCN assays , 2008, J. Comput. Aided Mol. Des..

[43]  Bojana Gligorijevic,et al.  Spinning disk confocal microscopy of live, intraerythrocytic malarial parasites. 2. Altered vacuolar volume regulation in drug resistant malaria. , 2006, Biochemistry.

[44]  David R. Cox,et al.  The Oxford Dictionary of Statistical Terms , 2006 .

[45]  Ting-Chao Chou,et al.  Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination Studies , 2006, Pharmacological Reviews.

[46]  D. Fidock,et al.  Decreasing pfmdr1 copy number in plasmodium falciparum malaria heightens susceptibility to mefloquine, lumefantrine, halofantrine, quinine, and artemisinin. , 2006, The Journal of infectious diseases.

[47]  F. Cohen,et al.  Searching for New Antimalarial Therapeutics amongst Known Drugs , 2006, Chemical biology & drug design.

[48]  A. Bell.  Antimalarial drug synergism and antagonism: mechanistic and clinical significance. , 2005, FEMS microbiology letters.

[49]  D. Fidock,et al.  pfmdr1 mutations contribute to quinine resistance and enhance mefloquine and artemisinin sensitivity in Plasmodium falciparum , 2005, Molecular microbiology.

[50]  Ruth H. Hughes,et al.  A critical role for PfCRT K76T in Plasmodium falciparum verapamil‐reversible chloroquine resistance , 2005, The EMBO journal.

[51]  S. Kuhn,et al.  Emergence of atovaquone-proguanil resistance during treatment of Plasmodium falciparum malaria acquired by a non-immune north American traveller to west Africa. , 2005, The American journal of tropical medicine and hygiene.

[52]  P. Wilairat,et al.  Simple and Inexpensive Fluorescence-Based Technique for High-Throughput Antimalarial Drug Screening , 2004, Antimicrobial Agents and Chemotherapy.

[53]  P. Roepe,et al.  Novel, Rapid, and Inexpensive Cell-Based Quantification of Antimalarial Drug Efficacy , 2004, Antimicrobial Agents and Chemotherapy.

[54]  K. Becker,et al.  Oxidative stress in malaria parasite-infected erythrocytes: host-parasite interactions. , 2004, International journal for parasitology.

[55]  S. Dzekunov,et al.  Drug resistance-associated pfCRT mutations confer decreased Plasmodium falciparum digestive vacuolar pH. , 2004, Molecular and biochemical parasitology.

[56]  A. Nzila,et al.  Towards an Understanding of the Mechanism of Pyrimethamine-Sulfadoxine Resistance in Plasmodium falciparum: Genotyping of Dihydrofolate Reductase and Dihydropteroate Synthase of Kenyan Parasites , 2000, Antimicrobial Agents and Chemotherapy.

[57]  Celia R. S. Garcia,et al.  Calcium homeostasis and signaling in the blood-stage malaria parasite. , 1999, Parasitology today.

[58]  W. Wernsdorfer,et al.  Synergism of benflumetol and artemether in Plasmodium falciparum. , 1999, The American journal of tropical medicine and hygiene.

[59]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[60]  J. Vanderberg.  Rodent malaria models. , 1991, Parasitology today.

[61]  A. Cowman,et al.  Chemotherapy and drug resistance in malaria. , 1990, International journal for parasitology.

[62]  D. Warhurst.  Chemotherapy and drug resistance in malaria (2nd edn): by W Peters, Academic Press, 1987. £63.00 (Vol. 1) £75.00 (Vol. 2) (1100 pages) ISBN 0 12 552721 7 , 1989 .

[63]  I. Gluzman,et al.  Efflux of chloroquine from Plasmodium falciparum: mechanism of chloroquine resistance. , 1987, Science.

[64]  T. Chou,et al.  Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. , 1984, Advances in enzyme regulation.

[65]  J. Haynes,et al.  Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique , 1979, Antimicrobial Agents and Chemotherapy.

[66]  R. Prim.  Shortest connection networks and some generalizations , 1957 .

[67]  P. Moran.  Notes on continuous stochastic phenomena. , 1950, Biometrika.